MARKSANS

What Marksans Pharma promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 18 tracked 4 delivered 1 missed 13 open
  • Operating Revenue delivered, diluted said Q4 FY25 Promised: Rs. 3,000 crores for FY26 Q1 FY27: Target period (FY26) has passed. Final verdict stands.
  • Teva Facility Revenue went quiet said Q4 FY25 Promised: Hit Rs. 1,000 crores eventually Q1 FY27: No specific update on the Teva facility revenue. A separate target for 'Goa Unit 2' was mentioned, but its relation to the larger Teva facility is unclear.
  • Operating Revenue diluted said Q4 FY26 Promised: Double revenue in the next 3 to 5 years (from ~INR 3,000 cr base). Q1 FY27: Management reiterated the goal but softened the timeline from '3 to 5 years' to 'within the next five years'.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 18 tracked commitments for Marksans Pharma — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens